tiprankstipranks
Dynavax Technologies’ $200M Share Buyback: Potential Risks and Financial Implications
PremiumCompany AnnouncementsDynavax Technologies’ $200M Share Buyback: Potential Risks and Financial Implications
2M ago
Dynavax Technologies Reports Strong Q3 2024 Results
Premium
Company Announcements
Dynavax Technologies Reports Strong Q3 2024 Results
2M ago
Dynavax announces $200M share repurchase program
Premium
The Fly
Dynavax announces $200M share repurchase program
2M ago
Dynavax adopts limited-duration stockholder rights plan
PremiumThe FlyDynavax adopts limited-duration stockholder rights plan
3M ago
Lantheus appoints Eastland as new board member
Premium
The Fly
Lantheus appoints Eastland as new board member
5M ago
Dynavax reports Q2 EPS 8c, consensus 6c
Premium
The Fly
Dynavax reports Q2 EPS 8c, consensus 6c
5M ago
Dynavax doses first patient in Phase 1/2 clinical trial evaluating Z-1018
PremiumThe FlyDynavax doses first patient in Phase 1/2 clinical trial evaluating Z-1018
7M ago
Dynavax Technologies (NASDAQ:DVAX): A Promising Biopharma Option Despite Recent Challenges
Premium
Market News
Dynavax Technologies (NASDAQ:DVAX): A Promising Biopharma Option Despite Recent Challenges
7M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100